Relationship Between Selected Parameters and Bruxism
Launched by WROCLAW MEDICAL UNIVERSITY · Dec 30, 2019
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Sleep breathing disorders are a frequent and serious health problem in the Polish population. Obstructive sleep apnea (OSA) is a common disorder. The essence of OSA is repeated episodes of airway obstruction that occur repeatedly during sleep, resulting in a decrease in the level of partial oxygen in the blood. Increased tension in the upper respiratory muscles and throat vibrations often result in very loud snoring. Apnea episodes end with awakenings that cause sleep fragmentation, deep sleep deficiency, and REM phase. Such episodes occur repeatedly, over a dozen or even several dozen time...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosed sleep bruxism
- • age between 18 and 70
- Exclusion Criteria:
- • age under 18
- • age over 70
- • terminal general diseases
- • severe mental disorders
- • taking drugs that could falsify polysomnography
- • confirmed alcoholism
- • drug addiction
About Wroclaw Medical University
Wrocław Medical University is a prestigious academic institution located in Wrocław, Poland, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in healthcare and biomedical sciences to facilitate innovative research initiatives aimed at improving patient outcomes. With a strong emphasis on ethical practices and regulatory compliance, Wrocław Medical University collaborates with a diverse network of healthcare professionals and researchers to conduct rigorous clinical trials that contribute to the development of new therapies and enhance the understanding of various medical conditions. Its dedication to scientific excellence and patient safety positions the university as a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wrocław, , Poland
Patients applied
Trial Officials
Mieszko Wieckiewicz, DMD, PhD
Study Chair
Wroclaw Medical University
Helena Martynowicz, MD, PhD
Principal Investigator
Wroclaw Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials